Vera Ignjatović: Looking Forward to AI in Thrombosis and Hemostasis Session at ISTH 2026

Vera Ignjatović, Founder and Managing Director at Ignis Innovations Pty Ltd, Principal Consultant of Translational Research at Johns Hopkins All Children’s Hospital, reposted from ISTH on LinkedIn:

”There is less than one week until the start of the International Society on Thrombosis and Haemostasis (ISTH), ISTH 2026 Congress in Paris!

I look forward to the many inspiring and thought-provoking sessions, and to catching up with colleagues from all corners of the World whom I have known for a long time, and with whom I have shared wonderful moments at the many ISTH meetings.

I also look forward to meeting new people and to creating new collaborations to answer clinically relevant questions that improve the outcomes – especially for children.

In addition, I am excited by the Special Sessions designed to explore the future of research, patient care and global collaboration.

As a passionate advocate for AI in Thrombosis and Hemostasis, I particularly look forward to this session:

• AI in Thrombosis and Hemostasis: Inspiration for our Society (July 14)
• Moderators and speakers: Vera Ignjatović, Suthesh Sivapalaratnam, Karin Leiderman, Rushad Patell

Artificial intelligence and machine learning are rapidly transforming research and clinical practice.

Explore the promises and challenges of AI in thrombosis and hemostasis, from harnessing big data to addressing ethics, bias and equitable representation in the next generation of healthcare innovation.”

Quoting International Society on Thrombosis and Haemostasis (ISTH)‘s post:

”What happens when the world’s leading experts come together to tackle the biggest challenges and opportunities in thrombosis and hemostasis?

At the ISTH 2026 Congress, our Special Sessions will go beyond traditional scientific programming to explore the conversations shaping the future of research, patient care and global collaboration.

This year’s lineup features four timely, thought-provoking sessions designed to inspire discussion and spark new ideas:

• The Journey from Discovery to Practice (July 11)
• Moderators and speakers: Françoise Dignat-George, Henri Spronk, Emmanuel Cormier, Helen Philippou, Philippe Poncelet, Pieter H. Reitsma, Peter Lenting

Hear directly from researchers and innovators on how groundbreaking discoveries become real-world therapies.

Learn about the challenges, successes and collaborations that drive translational science and how cross-sector partnerships are accelerating innovation.

• Building a Global Regulatory Collaboration Model to Bridge Evidence Gaps and Advance Women’s Health (July 12)
• Moderators and speakers: Flora Peyvandi, Donna DiMichele, Megha Kaushal, Robyn Langham, Daniela Philadelphy

A first-of-its-kind session bridging global regulatory agencies, scientific societies, patient advocates and researchers to discuss how collaboration can close evidence gaps and improve access to innovative therapies for women with inherited and acquired bleeding and clotting disorders.

• Periods, Pregnancy, Post-menopause, and Poverty: The Lancet Group Haematology Commission on Global Female Health and Haematology (July 13)
• Moderators and speakers: Bethany Bannow, Lan-Lan Smith, Dr. Maha Othman, Jecko Thachil, Luuk Scheres, Saskia Middeldorp

Join Commission authors as they examine critical issues affecting women worldwide, including heavy menstrual bleeding, postpartum hemorrhage, pregnancy-associated thrombosis, and disparities in maternal mortality.

The session concludes with an interactive discussion, and attendees will receive printed copies of the Commission.

• AI in Thrombosis and Hemostasis: Inspiration for our Society (July 14)
• Moderators and speakers: Vera Ignjatović, Suthesh Sivapalaratnam, Karin Leiderman, Rushad Patell,

Artificial intelligence and machine learning are rapidly transforming research and clinical practice.

Explore the promises and challenges of AI in thrombosis and hemostasis, from harnessing big data to addressing ethics, bias and equitable representation in the next generation of healthcare innovation.

Whether your interests are in fundamental science, clinical practice, public policy, women’s health or emerging technologies, the ISTH 2026 Special Sessions offer something you won’t want to miss”

Stay updated with Hemostasis Today.